Vascular abnormalities in scleroderma.
Authors:
- 1 March 1998
- journal article
- review article
- Published by Frontline Medical Communications, Inc. in Seminars in Cutaneous Medicine and Surgery
- Vol. 17 (1) , 12-17
Abstract
Vascular abnormalities represent a fundamental event in the pathogenesis of systemic sclerosis. This review focuses on key observations that support this view and builds a framework with which to clarify our understanding of how endothelial cell damage may trigger a self-fueling process ending in pathological tissue fibrosis in those susceptible to scleroderma. The studies reviewed in this article pertain to systemic sclerosis patients.Keywords
This publication has 37 references indexed in Scilit:
- Peroxynitrite: A two-faced metabolite of nitric oxideLife Sciences, 1997
- Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic optionsInternational Journal of Cardiology, 1997
- Decreased Expression of the Human Progenitor Cell Antigen (CD34) in MorpheaThe American Journal of Dermatopathology, 1995
- The Vascular Endothelium in SclerodermaInternational Reviews of Immunology, 1995
- A radical proposal for the pathogenesis of sclerodermaJournal of the American Academy of Dermatology, 1993
- Raynaud's phenomenon: its relevance to scleroderma.Annals of the Rheumatic Diseases, 1991
- Endothelin, an endothelial‐dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic actionArthritis & Rheumatism, 1991
- Elevated plasma levels of endothelin‐1 in systemic sclerosisArthritis & Rheumatism, 1991
- Prevalence of Raynaud phenomenon in the general populationJournal of Chronic Diseases, 1986
- DIFFUSE SCLERODERMA AND RAYNAUD'S DISEASE.British Journal of Dermatology, 1962